Unicycive Therapeutics Inc (NASDAQ: UNCY) is -52.17% lower on its value in year-to-date trading and has touched a low of $0.20 and a high of $1.82 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The UNCY stock was last observed hovering at around $0.42 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.41, the stock is 4.84% and 7.45% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.99 million and changing -0.65% at the moment leaves the stock -49.00% off its SMA200. UNCY registered -39.86% loss for a year compared to 6-month loss of -59.71%. The firm has a 50-day simple moving average (SMA 50) of $0.38624 and a 200-day simple moving average (SMA200) of $0.81382.
The stock witnessed a 1.19% gain in the last 1 month and extending the period to 3 months gives it a -2.35%, and is -3.26% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.48% over the week and 8.31% over the month.
Unicycive Therapeutics Inc (UNCY) has around 14 employees, a market worth around $39.16M and $0.00M in sales. Distance from 52-week low is 105.45% and -77.17% from its 52-week high. The company has generated returns on investments over the last 12 months (-95.94%).
The EPS is expected to grow by 42.97% this year.
Unicycive Therapeutics Inc (UNCY) Top Institutional Holders
30.0 institutions hold shares in Unicycive Therapeutics Inc (UNCY), with institutional investors hold 42.81% of the company’s shares. The shares outstanding are 94.36M, and float is at 84.53M with Short Float at 1.24%. Institutions hold 39.92% of the Float.
The top institutional shareholder in the company is VIVO CAPITAL, LLC with over 3.47 million shares valued at $1.74 million. The investor’s holdings represent 9.9395% of the UNCY Shares outstanding. As of 2024-06-30, the second largest holder is LOGOS GLOBAL MANAGEMENT LP with 3.47 million shares valued at $1.74 million to account for 9.9389 of the shares outstanding. The other top investors are NANTAHALA CAPITAL MANAGEMENT, LLC which holds 2.82 million shares representing 8.0783% and valued at over $1.41 million, while RA CAPITAL MANAGEMENT, L.P. holds 7.5394 of the shares totaling 2.63 million with a market value of $1.32 million.
Unicycive Therapeutics Inc (UNCY) Insider Activity
#####
